Related Experiment Video
Updated: Jul 6, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
The HapMap: charting a course for genetic discovery in neurological diseases
1Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, University College London, Queen Square, London WC1 3BG, England. j.hardy@ion.ucl.ac.uk
Whole-genome association studies are identifying genetic risk factors for complex diseases. This review covers their application to neurological diseases, explaining the methods and future potential.
Area of Science:
- Genetics
- Neurology
- Bioinformatics
Background:
- Whole-genome association studies (WGS) are increasingly successful in identifying genetic risk variants for complex diseases.
- The application of WGS to neurological disease is a rapidly developing field.
Purpose of the Study:
- To review the progress of WGS in identifying genetic risk variants for neurological diseases.
- To explain the principles underlying WGS analysis.
- To discuss the future directions and potential of WGS in neurology.
Main Methods:
- Review of published literature on WGS for complex and neurological diseases.
- Explanation of the statistical principles and methodologies of genome-wide association analyses.
- Synthesis of current findings and future projections.
Main Results:
- WGS has begun to yield confirmed findings for genetic risk variants in complex diseases.
- Early applications of WGS to neurological diseases are showing promising results.
Conclusions:
- WGS is a powerful tool for understanding the genetic basis of neurological disorders.
- Continued advancements in WGS technology and analysis will likely accelerate discoveries in neurological disease genetics.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenomics: Identification of New Drug Targets
Huntington Disease l: Introduction
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pedigree Analysis